OpenURL Connection Search

Select item for more details and to access through your institution.

First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia.
Published in:
Journal of the Pediatric Infectious Diseases Society, 2023, v. 12, n. 11, p. 581, doi. 10.1093/jpids/piad088
By:
- Chabala, Chishala;
- Jacobs, Tom G;
- Moraleda, Cinta;
- Ndaferankhande, John M;
- Mumbiro, Vivian;
- Passanduca, Alfeu;
- Namuziya, Natasha;
- Nalwanga, Damalie;
- Musiime, Victor;
- Ballesteros, Alvaro;
- Domínguez-Rodríguez, Sara;
- Chitsamatanga, Moses;
- Cassia, Uneisse;
- Nduna, Bwendo;
- Bramugy, Justina;
- Sacarlal, Jahit;
- Madrid, Lola;
- Nathoo, Kusum J;
- Colbers, Angela;
- Burger, David M
Publication type:
Article
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial.
Published in:
Clinical Infectious Diseases, 2024, v. 78, n. 3, p. 702, doi. 10.1093/cid/ciad656
By:
- Jacobs, Tom G;
- Mumbiro, Vivian;
- Cassia, Uneisse;
- Zimba, Kevin;
- Nalwanga, Damalie;
- Ballesteros, Alvaro;
- Domínguez-Rodríguez, Sara;
- Tagarro, Alfredo;
- Madrid, Lola;
- Mutata, Constantine;
- Chitsamatanga, Moses;
- Bwakura-Dangarembizi, Mutsa;
- Passanduca, Alfeu;
- Buck, W Chris;
- Nduna, Bwendo;
- Chabala, Chishala;
- Najjingo, Elizabeth;
- Musiime, Victor;
- Moraleda, Cinta;
- Colbers, Angela
Publication type:
Article
Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial.
Published in:
Clinical Infectious Diseases, 2023, v. 77, n. 9, p. 1312, doi. 10.1093/cid/ciad346
By:
- Bevers, Lisanne A H;
- Waalewijn, Hylke;
- Szubert, Alexander J;
- Chabala, Chishala;
- Bwakura-Dangarembizi, Mutsa;
- Makumbi, Shafic;
- Nangiya, Joan;
- Mumbiro, Vivian;
- Mulenga, Veronica;
- Musiime, Victor;
- Burger, David M;
- Gibb, Diana M;
- Colbers, Angela
Publication type:
Article
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
Published in:
Clinical Infectious Diseases, 2023, v. 77, n. 6, p. 875, doi. 10.1093/cid/ciad267
By:
- Waalewijn, Hylke;
- Szubert, Alexander J;
- Wasmann, Roeland E;
- Wiesner, Lubbe;
- Chabala, Chishala;
- Bwakura-Dangarembizi, Mutsa;
- Makumbi, Shafic;
- Nangiya, Joan;
- Mumbiro, Vivian;
- Mulenga, Veronica;
- Musiime, Victor;
- Monkiewicz, Lara N;
- Griffiths, Anna L;
- Bamford, Alasdair;
- Doerholt, Katja;
- Denti, Paolo;
- Burger, David M;
- Gibb, Diana M;
- McIlleron, Helen M;
- Colbers, Angela
Publication type:
Article
ADEQUATE DTG EXPOSURE IN INFANTS ON RIFAMPICIN TREATMENT RECEIVING TWICE-DAILY DTG.
Published in:
Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 332
By:
- Jacobs, Tom G.;
- Mumbiro, Vivian;
- Cassia, Uneisse;
- Nalwanga, Damalie;
- Zimba, Kevin;
- Dominguez, Sara;
- Mutata, Constantine;
- Buck, W. Chris;
- Chabala, Chishala
Publication type:
Article

Found: 5

First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia.

Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial.

Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial.

First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.

ADEQUATE DTG EXPOSURE IN INFANTS ON RIFAMPICIN TREATMENT RECEIVING TWICE-DAILY DTG.